FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4376116569> ?p ?o ?g. }

• W4376116569 endingPage "944" @default.
• W4376116569 startingPage "936" @default.
• W4376116569 abstract "Tapinarof cream 1% once daily demonstrated significant efficacy versus vehicle and was well tolerated in two 12-week, phase 3 pivotal trials in adults with mild-to-severe plaque psoriasis.To assess long-term, health-related quality of life and patient satisfaction with tapinarof.Patients completing the 12-week trials were eligible for 40 weeks of open-label tapinarof based on Physician Global Assessment score in PSOARING 3, with a 4-week follow-up. Dermatology Life Quality Index was assessed at every visit; Patient Satisfaction Questionnaire responses were assessed at week 40 or early termination.Seven hundred sixty-three (91.6%) eligible patients enrolled; 78.5% completed the Patient Satisfaction Questionnaire. DLQI scores improved and were maintained. By week 40, 68.0% of patients had a DLQI of 0 or 1, indicating no impact of psoriasis on health-related quality of life. Most patients strongly agreed or agreed with all Patient Satisfaction Questionnaire questions assessing confidence in tapinarof and satisfaction with efficacy (62.9%-85.8%), application ease and cosmetic elegance (79.9%-96.3%), and preference for tapinarof versus prior psoriasis therapies (55.3%-81.7%).Open-label; no control; may not be generalizable to all forms of psoriasis.Continued and durable improvements in health-related quality of life, high rates of patient satisfaction, and positive perceptions of tapinarof cream were demonstrated." @default.
• W4376116569 created "2023-05-12" @default.
• W4376116569 creator A5003122683 @default.
• W4376116569 creator A5012715289 @default.
• W4376116569 creator A5019624446 @default.
• W4376116569 creator A5048521405 @default.
• W4376116569 creator A5052851982 @default.
• W4376116569 creator A5063029492 @default.
• W4376116569 creator A5071209802 @default.
• W4376116569 creator A5075354896 @default.
• W4376116569 creator A5085051271 @default.
• W4376116569 date "2023-11-01" @default.
• W4376116569 modified "2023-10-12" @default.
• W4376116569 title "Tapinarof cream 1% once daily for the treatment of plaque psoriasis: Patient-reported outcomes from the PSOARING 3 trial" @default.
• W4376116569 cites W1995216400 @default.
• W4376116569 cites W2030298480 @default.
• W4376116569 cites W2058547807 @default.
• W4376116569 cites W2070309415 @default.
• W4376116569 cites W2080165152 @default.
• W4376116569 cites W2096991001 @default.
• W4376116569 cites W2144317224 @default.
• W4376116569 cites W2152262899 @default.
• W4376116569 cites W2166956380 @default.
• W4376116569 cites W2218980995 @default.
• W4376116569 cites W2410516238 @default.
• W4376116569 cites W2544907276 @default.
• W4376116569 cites W2556105556 @default.
• W4376116569 cites W2767862884 @default.
• W4376116569 cites W2790274149 @default.
• W4376116569 cites W2794352131 @default.
• W4376116569 cites W2911539412 @default.
• W4376116569 cites W2914164523 @default.
• W4376116569 cites W2953037197 @default.
• W4376116569 cites W2980508062 @default.
• W4376116569 cites W3004313513 @default.
• W4376116569 cites W3043007425 @default.
• W4376116569 cites W3045628073 @default.
• W4376116569 cites W3047284695 @default.
• W4376116569 cites W3130697528 @default.
• W4376116569 cites W3171329923 @default.
• W4376116569 cites W3194086089 @default.
• W4376116569 cites W3206815290 @default.
• W4376116569 cites W4200054824 @default.
• W4376116569 cites W4205675137 @default.
• W4376116569 cites W4223476634 @default.
• W4376116569 cites W4283591596 @default.
• W4376116569 cites W4324057458 @default.
• W4376116569 doi "https://doi.org/10.1016/j.jaad.2023.04.061" @default.
• W4376116569 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37172733" @default.
• W4376116569 hasPublicationYear "2023" @default.
• W4376116569 type Work @default.
• W4376116569 citedByCount "2" @default.
• W4376116569 countsByYear W43761165692023 @default.
• W4376116569 crossrefType "journal-article" @default.
• W4376116569 hasAuthorship W4376116569A5003122683 @default.
• W4376116569 hasAuthorship W4376116569A5012715289 @default.
• W4376116569 hasAuthorship W4376116569A5019624446 @default.
• W4376116569 hasAuthorship W4376116569A5048521405 @default.
• W4376116569 hasAuthorship W4376116569A5052851982 @default.
• W4376116569 hasAuthorship W4376116569A5063029492 @default.
• W4376116569 hasAuthorship W4376116569A5071209802 @default.
• W4376116569 hasAuthorship W4376116569A5075354896 @default.
• W4376116569 hasAuthorship W4376116569A5085051271 @default.
• W4376116569 hasBestOaLocation W43761165691 @default.
• W4376116569 hasConcept C126322002 @default.
• W4376116569 hasConcept C141071460 @default.
• W4376116569 hasConcept C159110408 @default.
• W4376116569 hasConcept C16005928 @default.
• W4376116569 hasConcept C168563851 @default.
• W4376116569 hasConcept C1862650 @default.
• W4376116569 hasConcept C2775944032 @default.
• W4376116569 hasConcept C2776173921 @default.
• W4376116569 hasConcept C2779951463 @default.
• W4376116569 hasConcept C2780564577 @default.
• W4376116569 hasConcept C3019800554 @default.
• W4376116569 hasConcept C3020604521 @default.
• W4376116569 hasConcept C44249647 @default.
• W4376116569 hasConcept C535046627 @default.
• W4376116569 hasConcept C71924100 @default.
• W4376116569 hasConceptScore W4376116569C126322002 @default.
• W4376116569 hasConceptScore W4376116569C141071460 @default.
• W4376116569 hasConceptScore W4376116569C159110408 @default.
• W4376116569 hasConceptScore W4376116569C16005928 @default.
• W4376116569 hasConceptScore W4376116569C168563851 @default.
• W4376116569 hasConceptScore W4376116569C1862650 @default.
• W4376116569 hasConceptScore W4376116569C2775944032 @default.
• W4376116569 hasConceptScore W4376116569C2776173921 @default.
• W4376116569 hasConceptScore W4376116569C2779951463 @default.
• W4376116569 hasConceptScore W4376116569C2780564577 @default.
• W4376116569 hasConceptScore W4376116569C3019800554 @default.
• W4376116569 hasConceptScore W4376116569C3020604521 @default.
• W4376116569 hasConceptScore W4376116569C44249647 @default.
• W4376116569 hasConceptScore W4376116569C535046627 @default.
• W4376116569 hasConceptScore W4376116569C71924100 @default.
• W4376116569 hasIssue "5" @default.
• W4376116569 hasLocation W43761165691 @default.
• W4376116569 hasLocation W43761165692 @default.
• W4376116569 hasOpenAccess W4376116569 @default.

• next